The U.S. healthcare industry and analysts praised a U.S. Supreme Court decision that preserved the Obamacare health plan, with insurer CVS reaffirming that it will rejoin the individual insurance exchange and others predicting more federal support.
Cruise operator Carnival Corp said on Thursday it had detected unauthorized access to its computer systems in March, after which it alerted regulators and hired a cybersecurity firm to investigate the breach.
Cruise operator Carnival Corp detected unauthorized access to its computer systems in March, alerted regulators and hired a cybersecurity firm to investigate the breach, Bloomberg News reported on Thursday.
Kroger Co raised its forecast for annual profit on Thursday, betting that its quick pickup and delivery services will encourage Americans to order groceries online even as they dine out again.
Miners knocked London's FTSE 100 index off 16-month highs on Thursday as a hawkish turn by the U.S. Federal Reserve hit commodity prices, although Britain's plans to ease travel restrictions allowed airline shares to buck the trend.
German biotech firm CureVac saw billions of euros wiped from its market value on Thursday after its COVID-19 vaccine proved only 47% effective in an initial trial read-out, denting investor confidence in its ability to take on rival shots.
Medical equipment maker Danaher Corp said on Thursday it would buy privately held biotech company Aldevron in an all-cash deal for about $9.6 billion, snapping up a supplier to COVID-19 vaccine maker Moderna Inc .
The low dosage might be a key reason why CureVac's COVID-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said on Thursday.
Pan-European financial markets operator Euronext said on Thursday that it had resolved the technical glitches which knocked out index derivatives trading for nearly four hours earlier in the day.
CureVac shares fell by as much as 52% on Thursday after the German biotech's COVID-19 vaccine proved only 47% effective in an initial trial, denting investor confidence in its ability to take on established rivals.
WASHINGTON (Reuters) -U.S. Senate Majority Leader Chuck Schumer on Thursday met with members of a bipartisan group of senators struggling to develop an infrastructure proposal that could make it through Congress while achieving President Joe Biden's goals.